UK-specific cost-effectiveness of tiotropium + olodaterol fixed-dose combination versus other LAMA + LABA combinations in patients with COPD

by Tebboth A, Ternouth A, Gonzalez-Rojas N
Published 2016-11-01

The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK

by Edwards SC, Fairbrother SE, Scowcroft A, Chiu G, Ternouth A, Lipworth BJ
Published 2016-11-01

Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK

by Eklund O, Afzal F, Borgström F, Flavin J, Ternouth A, Ojanguren ME, Crespo C, Baldwin M
Published 2016-06-01